Google Chrome
Safari
Firefox
Edge
Search
Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
News / Jun 28, 2022
PhD student represents Hovione in the iconic photo featuring Curie and Einstein
CEFIC remakes the iconic 1927 photo. 34 renowned chemistry professors and 21 young European scientists recreate the iconic photo featuring Curie and Einstein
News / Apr 19, 2023
Hovione is recognised as a LinkedIn Top Company in Portugal
This recognition comes after Hovione was recognized as a Top Employer in Portugal, the United States and Ireland.
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Press Release / Dec 02, 2025
Hovione and GEA set new standards for continuous tableting
The new ConsiGma® CDC Flex delivers unprecedented flexibility, simplicity, and cost-efficiency in continuous direct compression.
News / Apr 12, 2021
Guy Villax wins EY Award “Entrepreneur of the Year”
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
Article / Oct 10, 2022
Hovione’s Continuous Manufacturing Facility, Loures, Portugal
Pharmaceutical Technology, 10 October 2022
Press Release / Nov 29, 2023
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.